Clinical trial · Observational
Cohort Study of Intrauterine Diseases
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
"This study employs a prospective cohort design by establishing a uterine cavity diseases research platform. The investigators will collect participants' current medical history, menstrual and obstetric history, past medical history, physical and gynecological examinations, imaging studies, laboratory tests, and pathological examinations. After the hysteroscopic surgery, the investigators will conduct a one-year follow-up on the disease progression of the participants. Through this comprehensive approach, the investigators aim to deeply investigate the pathogenesis, risk factors, and optimized treatment strategies for uterine cavity diseases."
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
| Endometrial Hyperplasia | — | UNRESOLVED | — |
| Endometrial Polyps | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention (observational study) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Intrauterine Diseases Cohort
- description
- Disease-specific cohort for uterine cavity diseases
- interventionNames
- Other: No intervention (observational study)
Primary outcomes (1)
- measure
- The recurrence of endometrial polyps or endometrial hyperplasia.
- timeFrame
- Follow up every three months for one year after hysteroscopic surgery
- description
- To evaluate the presence of disease progression and recurrence through imaging results.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Age: 18-80 years; * Patients requiring hysteroscopy or diagnostic curettage for intrauterine pathologies (e.g., endometrial hyperplasia, endometrial polyps, submucosal uterine fibroids, adenomyosis, or endometrial malignancies); * Willing and able to comply with follow-up requirements; * Signed informed consent obtained. Exclusion Criteria: * Concurrent participation in other drug clinical trials; * Contraindications to or inability to tolerate hysteroscopy/curettage procedures; * Unwilling or unable to provide informed consent; * Unwilling or unable to adhere to study protocols.
References
Publications (0)
Data not yet available